CLINICAL STUDY: CONNEXIN AND INFARCTION
Connexin43 as a determinant of myocardial infarct size following coronary occlusion in mice
Shigeto Kanno, MD, PhD*,
Attila Kovacs, MD*,
Kathryn A. Yamada, PhD* and
Jeffrey E. Saffitz, MD, PhD, FACC*,*
* Departments of Surgery, Medicine, and Pathology, and the Center for Cardiovascular Research, Washington University School of Medicine, St. Louis, Missouri, USA
Manuscript received July 12, 2002;
revised manuscript received September 30, 2002,
accepted November 19, 2002.
* Reprint requests and correspondence: Dr. Jeffrey E. Saffitz, Washington University, Department of Pathology, Box 8118, 660 South Euclid Avenue, St. Louis, Missouri 63110USA.
OBJECTIVES: The purpose of this study was to define the role of cell–cell coupling as an independent determinant of infarct size following coronary occlusion.
BACKGROUND: Electrical uncoupling induced by acute ischemia enhances arrhythmogenesis, but it may also protect the heart by limiting intercellular spread of chemical mediators of injury.
METHODS: The left anterior descending coronary artery was ligated in wild-type (Cx43+/+) mice and Cx43-deficient (Cx43+/–) mice that are heterozygous for a null allele in the gene encoding the major gap junction channel protein, connexin43 (Cx43). Ventricular remodeling and infarct size were compared in both groups.
RESULTS: Echocardiography at 1 and 10 weeks after infarction showed that left ventricular end-diastolic volume and mass increased and ejection fraction decreased in proportion to infarct size in both Cx43+/– and Cx43+/+ hearts. However, infarct size measured histologically in healing infarcts (eight days after infarction) was 29% smaller in Cx43+/– hearts (17 ± 14% of total left ventricular area, n = 30) than in Cx43+/+ hearts (24 ± 15%, n = 23; p = 0.037). Fully healed infarcts were smaller than healing infarcts, owing to resorption of necrotic tissue and maturation of scar, but infarct size at 10 weeks after coronary occlusion was still smaller (by 50%) in Cx43+/– hearts (6 ± 5%, n = 9) compared with Cx43+/+ hearts (12 ± 7%, n = 17; p = 0.037).
CONCLUSIONS: Cx43-deficient mice develop smaller infarcts than wild-type mice following coronary ligation. New therapies designed to decrease the risk of arrhythmias by enhancing intercellular communication could lead to larger infarcts caused by persistent coronary occlusion.
|
Abbreviations and Acronyms
| | Cx43 | | connexin43 | | Cx43+/+ | | mice with two wild-type alleles for the Cx43 gene | | Cx43+/– | | mice with one null allele for the Cx43 gene | | LAD | | left anterior descending coronary artery | | LV | | left ventricle or ventricular | | MI | | myocardial infarct or infarction |
|
This article has been cited by other articles:
|
|
|
|
 
A. Hagen, A. Dietze, and S. Dhein
Human cardiac gap-junction coupling: effects of antiarrhythmic peptide AAP10
Cardiovasc Res,
July 15, 2009;
83(2):
405 - 415.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. Severs, A. F. Bruce, E. Dupont, and S. Rothery
Remodelling of gap junctions and connexin expression in diseased myocardium
Cardiovasc Res,
October 1, 2008;
80(1):
9 - 19.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H.-C. Lin, N. Lou, N. Kang, T. Takano, F. Hu, X. Han, Q. Xu, D. Lovatt, A. Torres, K. Willecke, et al.
A Central Role of Connexin 43 in Hypoxic Preconditioning
J. Neurosci.,
January 16, 2008;
28(3):
681 - 695.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ruiz-Meana, A. Rodriguez-Sinovas, A. Cabestrero, K. Boengler, G. Heusch, and D. Garcia-Dorado
Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury
Cardiovasc Res,
January 15, 2008;
77(2):
325 - 333.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Wit and H. S. Duffy
Drug development for treatment of cardiac arrhythmias: targeting the gap junctions
Am J Physiol Heart Circ Physiol,
January 1, 2008;
294(1):
H16 - H18.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Murphy and C. Steenbergen
Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury
Cardiovasc Res,
August 1, 2007;
75(3):
478 - 486.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Kojodjojo, P. Kanagaratnam, O. R. Segal, W. Hussain, and N. S. Peters
The Effects of Carbenoxolone on Human Myocardial Conduction: A Tool to Investigate the Role of Gap Junctional Uncoupling in Human Arrhythmogenesis
J. Am. Coll. Cardiol.,
September 19, 2006;
48(6):
1242 - 1249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. K. Hennan, R. E. Swillo, G. A. Morgan, J. C. Keith Jr., R. G. Schaub, R. P. Smith, H. S. Feldman, K. Haugan, J. Kantrowitz, P. J. Wang, et al.
Rotigaptide (ZP123) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs
J. Pharmacol. Exp. Ther.,
April 1, 2006;
317(1):
236 - 243.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rodriguez-Sinovas, D. Garcia-Dorado, M. Ruiz-Meana, and J. Soler-Soler
Protective effect of gap junction uncouplers given during hypoxia against reoxygenation injury in isolated rat hearts
Am J Physiol Heart Circ Physiol,
February 1, 2006;
290(2):
H648 - H656.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Iacobas, S. Iacobas, W. E. I. Li, G. Zoidl, R. Dermietzel, and D. C. Spray
Genes controlling multiple functional pathways are transcriptionally regulated in connexin43 null mouse heart
Physiol Genomics,
February 10, 2005;
20(3):
211 - 223.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Turner, G. A. Haywood, P. Andreka, L. You, P. E. Martin, W. H. Evans, K. A. Webster, and N. H. Bishopric
Reversible Connexin 43 Dephosphorylation During Hypoxia and Reoxygenation Is Linked to Cellular ATP Levels
Circ. Res.,
October 1, 2004;
95(7):
726 - 733.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rodriguez-Sinovas, D. Garcia-Dorado, M. Ruiz-Meana, and J. Soler-Soler
Enhanced effect of gap junction uncouplers on macroscopic electrical properties of reperfused myocardium
J. Physiol.,
August 15, 2004;
559(1):
245 - 257.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T.-M. Lee, M.-S. Lin, T.-F. Chou, C.-H. Tsai, and N.-C. Chang
Adjunctive 17{beta}-estradiol administration reduces infarct size by altered expression of canine myocardial connexin43 protein
Cardiovasc Res,
July 1, 2004;
63(1):
109 - 117.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Dhein
Pharmacology of gap junctions in the cardiovascular system
Cardiovasc Res,
May 1, 2004;
62(2):
287 - 298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Gros, L. Dupays, S. Alcolea, S. Meysen, L. Miquerol, and M. Theveniau-Ruissy
Genetically modified mice: tools to decode the functions of connexins in the heart--new models for cardiovascular research
Cardiovasc Res,
May 1, 2004;
62(2):
299 - 308.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Schulz and G. Heusch
Connexin 43 and ischemic preconditioning
Cardiovasc Res,
May 1, 2004;
62(2):
335 - 344.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. Severs, S. R. Coppen, E. Dupont, H.-I Yeh, Y.-S. Ko, and T. Matsushita
Gap junction alterations in human cardiac disease
Cardiovasc Res,
May 1, 2004;
62(2):
368 - 377.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Camelliti, G. P Devlin, K. G Matthews, P. Kohl, and C. R Green
Spatially and temporally distinct expression of fibroblast connexins after sheep ventricular infarction
Cardiovasc Res,
May 1, 2004;
62(2):
415 - 425.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Gattenlohner, C. Waller, G. Ertl, B.-D. Bultmann, H.-K. Muller-Hermelink, and A. Marx
NCAM(CD56) and RUNX1(AML1) Are Up-Regulated in Human Ischemic Cardiomyopathy and a Rat Model of Chronic Cardiac Ischemia
Am. J. Pathol.,
September 1, 2003;
163(3):
1081 - 1090.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Gu, F. C. Smith, S. M. Taffet, and M. Delmar
High Incidence of Cardiac Malformations in Connexin40-Deficient Mice
Circ. Res.,
August 8, 2003;
93(3):
201 - 206.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
